|
|
Article: ACADIA Pharmaceuticals Secures Committed Equity Financing Facility.
- Article from:
- Biotech Week
- Article date:
- August 20, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, announced that it has entered into a Committed Equity Financing Facility (CEFF) with Kingsbridge Capital Limited in which Kingsbridge has committed to provide up to $60 million of capital during the next three years through the purchase of newly-issued shares of ACADIA's common stock (see also ACADIA Pharmaceuticals Inc.).
"The new CEFF with Kingsbridge provides us with added financial flexibility and strength as we move forward with a portfolio of our most ...